Dr. David A. Bridgeman, MD

Dr. Bridgeman practices at Graybill Medical Group Inc in Fallbrook, California.

Dr. Bridgeman's NPI, 1134147986, was assigned on July 18, 2006. Dr. Bridgeman graduated from David Geffen School of Medicine at UCLA in 1997. Dr. Bridgeman holds California license A67370.

Dr. Bridgeman's primary practice is Graybill Medical Group Inc, at 1035 S Main Ave, Fallbrook, CA 92028 in San Diego County. The practice phone is (760) 291-6700.

Dr. Bridgeman's primary practice is Graybill Medical Group Inc in Fallbrook, California. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Bridgeman to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bridgeman practices, 3 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Bridgeman's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Bridgeman is board certified in family medicine by the American Board of Family Medicine. Dr. Bridgeman is licensed in California.

Dmand AI lists acute mini-stroke (TIA), acute sinusitis, acute skin infection, alcohol use disorders, anxiety, arthritis, benign or precancerous skin growths and bursitis among the conditions Dr. Bridgeman treats.

CMS data shows 890 Medicare services from Dr. Bridgeman across 12 procedure codes in 2024, for 272 Medicare patients. Medicare paid $51,199 for them. Every service was in an office.

CMS counts 272 Medicare patients who saw Dr. Bridgeman in 2024. The largest group is 65 to 74, with 121 patients. 58% of them have high blood pressure, and 54% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bridgeman's median patient age at 65, with 47% women.

In 2024, Dr. Bridgeman wrote 4,361 Medicare Part D claims for 547 patients. 89% of them were for generic drugs. CMS names the drug for 3,743 of them, across 92 drugs with 11 or more claims each, at $540,977 in total drug cost. In 2023, CMS named 3,799 claims across 95 drugs.

Dr. Bridgeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bridgeman as offering telehealth. CMS counts 12 procedures of removal of skin lesions by Dr. Bridgeman, more than 59% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 221 general payments to Dr. Bridgeman from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $603.

Dmand AI lists 1 award for Dr. Bridgeman, most recently CMS Stage 1 EHR in 2013.

Dr. Bridgeman graduated from David Geffen School of Medicine at UCLA in 1997.

Dr. Bridgeman is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.